HighVista Strategies’s St Jude Medical STJ Stock Holding History

HighVista Strategies’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-258,637	Closed	-$20.7M	–	203
2016 Q4	$20.7M	Buy	258,637 +31,560	+14%	+$2.5M	4.07%	2
2016 Q3	$18.1M	Buy	227,077 +31,560	+16%	+$2.55M	3.36%	3
2016 Q2	$15.3M	Buy	195,517 +168,013	+611%	+$12M	2.91%	6
2016 Q1	$1.51M	Buy	27,504 +3,500	+15%	+$191K	0.28%	103
2015 Q4	$1.48M	Buy	+24,004	New	+$1.51M	0.28%	91
2014 Q4	–	Sell	-3,464	Closed	-$208K	–	201
2014 Q3	$208K	Buy	+3,464	New	+$226K	0.03%	155
2014 Q2	–	Sell	-3,591	Closed	-$227K	–	178
2014 Q1	$227K	Buy	+3,591	New	+$234K	0.03%	138

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

HighVista Strategies's STJ Position: Q1 2017 in Review

HighVista Strategies sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 258,637 shares — an estimated $20.7M sold.

HighVista Strategies first reported a position in STJ in Q1 2014 and held it in 7 quarters. The position peaked at $20.7M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

HighVista Strategies reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
HighVista Strategies sold 258,637 St Jude Medical shares in Q1 2017, an estimated $20.7M.
HighVista Strategies first reported a position in St Jude Medical in Q1 2014 and held it in 7 quarters.
HighVista Strategies's St Jude Medical position peaked at $20.7M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on HighVista Strategies's 13F filing for Q1 2017, filed 15 May 2017.